Glucotrack (GCTK) Other Accumulated Expenses (2010 - 2025)

Glucotrack has disclosed Other Accumulated Expenses across 16 years of filings, most recently posting $246000.0 for Q4 2025.

• Quarterly Other Accumulated Expenses fell 2.38% year-over-year to $246000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $246000.0 (down 2.38% YoY) and the FY2025 annual result came in at $246000.0, down 2.38% from the prior year.
• Other Accumulated Expenses retreated to $246000.0 in Q4 2025, from $529000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $887000.0 in Q2 2024 and troughed at $205000.0 in Q3 2023.
• A 5-year average of $383900.0 and a median of $316000.0 in 2022 frame the typical range for Other Accumulated Expenses.
• Biggest YoY gain for Other Accumulated Expenses was 306.88% in 2024; the steepest drop was 62.56% in 2024.
• Tracing GCTK's Other Accumulated Expenses over 5 years: stood at $229000.0 in 2021, then jumped by 48.91% to $341000.0 in 2022, then surged by 97.36% to $673000.0 in 2023, then sank by 62.56% to $252000.0 in 2024, then retreated by 2.38% to $246000.0 in 2025.
• Business Quant data shows GCTK's Other Accumulated Expenses at $246000.0 in Q4 2025, $529000.0 in Q3 2025, and $414000.0 in Q2 2025.